Revvity (RVTY) Current Deferred Revenue (2014 - 2016)
Revvity (RVTY) reported Current Deferred Revenue of $163.2 million for Q1 2016, down 3.41% on a YoY basis from $168.9 million in Q1 2015, and down 3.41% quarter-over-quarter from $168.9 million in Q4 2014.
Revvity (RVTY) Current Deferred Revenue (2014 - 2016) Analysis & Trends
Revvity has reported Current Deferred Revenue for 2 years, with the latest figure at $163.2 million in Q1 2016.
- For the quarter ending Q1 2016, Current Deferred Revenue fell 3.41% year-over-year to $163.2 million; the trailing twelve-month figure through Jan 2016 stood at $163.2 million (down 3.41% YoY), and the FY2016 full-year result was $163.2 million, down 3.41% from the prior year.
- Current Deferred Revenue for Q1 2016 stood at $163.2 million, down from $168.9 million in the prior quarter.
- The five-year high for Current Deferred Revenue was $168.9 million in Q4 2014, with the low at $163.2 million in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn |
| 10 | Revvity | 11.23 Bn | 10.37 Bn | 387.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 3, 2016 | 163.17 Mn |
| Dec 28, 2014 | 168.93 Mn |